| 1 |
Namazi H, Pooresmaeil M, Salehi R. Construction of a new dual-drug delivery system based on stimuli-responsive co-polymer functionalized D-mannose for chemotherapy of breast cancer. European Polymer Journal 2023;188:111958. [DOI: 10.1016/j.eurpolymj.2023.111958] [Reference Citation Analysis]
|
| 2 |
Aloss K, Hamar P. Recent Preclinical and Clinical Progress in Liposomal Doxorubicin. Pharmaceutics 2023;15:893. [DOI: 10.3390/pharmaceutics15030893] [Reference Citation Analysis]
|
| 3 |
Simón M, Jørgensen JT, Norregaard K, Henriksen JR, Clergeaud G, Andresen TL, Hansen AE, Kjaer A. Neoadjuvant Gold Nanoshell-Based Photothermal Therapy Combined with Liposomal Doxorubicin in a Mouse Model of Colorectal Cancer. Int J Nanomedicine 2023;18:829-41. [PMID: 36824412 DOI: 10.2147/IJN.S389260] [Reference Citation Analysis]
|
| 4 |
Hashemi M, Ghadyani F, Hasani S, Olyaee Y, Raei B, Khodadadi M, Ziyarani MF, Basti FA, Tavakolpournegari A, Matinahmadi A, Salimimoghadam S, Aref AR, Taheriazam A, Entezari M, Ertas YN. Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104112] [Reference Citation Analysis]
|
| 5 |
Li M, Chen H, Peng D, Lu X, Kong J, Luo S, Li S, Tan C, Wang Y. FU-coating pH-sensitive liposomes for improving the release of gemcitabine by endosome escape in pancreatic cancer cells. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104135] [Reference Citation Analysis]
|
| 6 |
Sonju JJ, Dahal A, Prasasty VD, Shrestha P, Liu YY, Jois SD. Assessment of Antitumor and Antiproliferative Efficacy and Detection of Protein-Protein Interactions in Cancer Cells from 3D Tumor Spheroids. Curr Protoc 2022;2:e569. [PMID: 36286844 DOI: 10.1002/cpz1.569] [Reference Citation Analysis]
|
| 7 |
Ding H, Tan P, Fu S, Tian X, Zhang H, Ma X, Gu Z, Luo K. Preparation and application of pH-responsive drug delivery systems. J Control Release 2022:S0168-3659(22)00327-3. [PMID: 35660634 DOI: 10.1016/j.jconrel.2022.05.056] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
|
